[Nintedanib in progressive fibrosing interstitial lung diseases]
Z Rheumatol
.
2020 May;79(4):393-394.
doi: 10.1007/s00393-020-00782-7.
[Article in German]
Author
D Hadjiski
1
Affiliation
1
Gemeinschaftspraxis für Rheumatologie, Tätigkeitschwerpunkt Klinische Immunologie, Beethovenstr. 2, 76530, Baden-Baden, Deutschland. d.hadjiski@rheuma-badenbaden.de.
PMID:
32246191
DOI:
10.1007/s00393-020-00782-7
No abstract available
MeSH terms
Humans
Indoles / therapeutic use*
Lung Diseases, Interstitial* / drug therapy
Pulmonary Fibrosis* / drug therapy
Treatment Outcome
Substances
Indoles
nintedanib